Biologics Drug Development Market Insights Video

According to Cognitive Market Research, the global Biologics Drug Development market size was USD 7551.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 8.50% from 2024 to 2031.

• North America held the major market share for more than 40% of the global revenue with a market size of USD 3020.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031.
• Europe accounted for a market share of over 30% of the global revenue with a market size of USD 2265.36 million.
• Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 1736.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.5% from 2024 to 2031.
• Latin America had a market share of more than 5% of the global revenue with a market size of USD 377.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2031.
• Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 151.02 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2031.
• The In-House category is the fastest growing segment of the Biologics Drug Development industry